Skip to Content

Optimizing Venetoclax Treatment of Acute Myeloid Leukemia

Download PQI pdf 0.22MB

Last Updated: April 24, 2024

By: Seema Patel, PharmD

About this PQI

The purpose of this PQI is to highlight processes that can be implemented to minimize delays when treating acute myeloid leukemia (AML) with combination venetoclax and hypomethylating agent (HMA) therapy. Additionally, it will review the optimization of venetoclax treatment initiation and ongoing patient management.

More About This PQI

PQI in Action Articles:
PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI